Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility.

Autor: Dhara S; Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH, USA., Chhangawala S; Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chintalapudi H; Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH, USA., Askan G; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Aveson V; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Massa AL; Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH, USA., Zhang L; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Torres D; Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH, USA., Makohon-Moore AP; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lecomte N; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melchor JP; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bermeo J; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cardenas A 3rd; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sinha S; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Glassman D; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nicolle R; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre Le Cancer, Paris, France., Moffitt R; Stony Brook University, Stony Brook, NY, USA., Yu KH; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leppanen S; Agilent Technologies Inc., Santa Clara, CA, USA., Laderman S; Agilent Technologies Inc., Santa Clara, CA, USA., Curry B; Agilent Technologies Inc., Santa Clara, CA, USA., Gui J; Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH, USA., Balachandran VP; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iacobuzio-Donahue C; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chandwani R; Weill Cornell Medicine, New York, NY, USA., Leslie CS; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. cleslie@cbio.mskcc.org., Leach SD; Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH, USA. sdl@dartmouth.edu.

Publikováno v: Nature communications [Nat Commun] 2021 May 24; Vol. 12 (1), pp. 3044. Date of Electronic Publication: 2021 May 24.